GPNX
NOTIFICATION PROCESSED BY IB
08/06/2023
Back to search
Official data from USPTO
LEAPER
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
15
Latest update
08/06/2023
Trademark type
Word
Nice classes
5, 42
Filing date
05/07/2022
Registration date
05/30/2023
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
05/30/2023
Last transaction
05/30/2023
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
4
Owner type
03
Owner location
CN
Examiner
OSGOOD, KRYSTINA E
Law office
N30
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
EDIGENE INC.
Representatives
Chofn Intellectual Property
Technical classification
Nice Classes
Class 5Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Cells for medical or clinical use; pharmaceutical preparations in the nature of genetically modified therapeutic pharmaceuticals for the treatment of cardiovascularcentral nervous systemendocrinegastrointestinalgenetic immunologicalinfectiousinflammatorymenopausalmetabolicautoimmunemusculoskeletalneurologicalophthalmologicalpsychiatricrespiratoryurogenitalurologicalhematologic and viral diseases and disorderserectile dysfunctionsexual dysfunctioncancerpain and diabetes; pharmaceutical preparations in the nature of genetically modified therapeutic pharmaceuticalsantifungal preparationsmedicated dermatological preparations and substancessmoking cessation preparations and tissue repair preparations in the nature of biological tissue grafts; diagnostic reagents for medicinal use
Class 42
Medical and scientific research in the field of genome editinggene editinggenome engineeringgene modulationtranscriptional regulationtranscriptional modulationgenetic diseasesgene therapy and cell therapy; medical and scientific research information in the field of genome editinggene editinggenome engineeringgene modulationtranscriptional regulationtranscriptional modulationgenetic diseasesgene therapy and cell therapy; pharmaceutical research and development; pharmaceutical research services; providing medical and scientific research information in the fields of pharmaceuticals and genetics
Publications
History of USPTO decisions and trademark events.
15 publications found
FICS
FINAL DISPOSITION NOTICE SENT TO IB
07/20/2023
FIMP
FINAL DISPOSITION PROCESSED
07/20/2023
GPAR
GRANT OF PROTECTION CREATED, TO BE SENT TO IB
06/29/2023
R.PR
REGISTERED-PRINCIPAL REGISTER
05/30/2023
GPNX
NOTIFICATION PROCESSED BY IB
03/15/2023
PUBO
PUBLISHED FOR OPPOSITION
03/14/2023
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
02/22/2023
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
02/22/2023
NPUB
NOTICE OF PUBLICATION
02/22/2023
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
02/03/2023
DOCK
ASSIGNED TO EXAMINER
02/02/2023
MAFR
APPLICATION FILING RECEIPT MAILED
08/02/2022
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
07/29/2022
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
07/28/2022
Continuous trademark protection
Get notified about every new filing that threatens LEAPER or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.